Double maintains 2 strategies that include OCUL - Ocular Therapeutix, Inc.
Current Value
$7.161 Year Return
Current Value
$7.161 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 62.71% | $4.85B | 0.35% |
GNOM | 57.61% | $40.65M | 0.5% |
IBB | 57.02% | $5.22B | 0.45% |
PBE | 54.92% | $214.12M | 0.58% |
PTH | 54.77% | $96.56M | 0.6% |
ARKG | 53.00% | $944.78M | 0.75% |
XPH | 52.23% | $136.58M | 0.35% |
CPRJ | 51.84% | $48.43M | 0.69% |
FBT | 51.49% | $994.71M | 0.56% |
IWO | 51.29% | $11.36B | 0.24% |
IWC | 51.19% | $766.88M | 0.6% |
PINK | 50.76% | $131.52M | 0.5% |
VTWO | 49.59% | $12.07B | 0.07% |
IWM | 49.54% | $63.95B | 0.19% |
KJAN | 49.30% | $305.13M | 0.79% |
BBH | 48.43% | $327.42M | 0.35% |
ISCG | 48.39% | $645.00M | 0.06% |
SCHA | 48.03% | $16.91B | 0.04% |
NUSC | 47.53% | $1.14B | 0.31% |
ESML | 47.41% | $1.81B | 0.17% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
EYPT | 60.15% | $393.60M | -54.31% | 0.00% |
DNLI | 52.39% | $2.06B | -30.04% | 0.00% |
IMVT | 50.87% | $2.36B | -55.78% | 0.00% |
XENE | 49.17% | $2.27B | -26.70% | 0.00% |
APGE | 48.77% | $2.42B | -24.39% | 0.00% |
BEAM | 48.71% | $1.73B | -27.49% | 0.00% |
NRIX | 48.00% | $721.19M | -38.57% | 0.00% |
DAWN | 47.28% | $624.39M | -61.57% | 0.00% |
YMAB | 47.14% | $174.80M | -67.43% | 0.00% |
RVMD | 47.12% | $7.35B | +1.15% | 0.00% |
BHVN | 47.09% | $1.62B | -58.86% | 0.00% |
ACLX | 46.95% | $3.22B | +10.72% | 0.00% |
ARWR | 46.74% | $2.12B | -38.64% | 0.00% |
ROIV | 46.60% | $7.68B | -5.70% | 0.00% |
AUTL | 46.43% | $343.32M | -68.30% | 0.00% |
CRNX | 46.42% | $2.92B | -39.88% | 0.00% |
IDYA | 46.12% | $1.52B | -58.32% | 0.00% |
VRDN | 45.58% | $1.03B | -13.74% | 0.00% |
RCKT | 45.48% | $724.54M | -71.26% | 0.00% |
ATXS | 45.44% | $225.17M | -57.69% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -17.29% | $22.95B | +20.67% | 1.12% |
K | -11.02% | $28.49B | +32.17% | 2.77% |
LITB | -8.21% | $21.28M | -72.45% | 0.00% |
FMTO | -7.30% | $45.74M | -99.96% | 0.00% |
ED | -6.79% | $36.75B | +5.26% | 3.28% |
MO | -6.63% | $97.80B | +26.35% | 6.94% |
T | -5.50% | $196.66B | +57.98% | 4.07% |
NEUE | -4.67% | $62.05M | +13.56% | 0.00% |
QXO | -3.81% | $8.44B | -84.99% | 0.00% |
VZ | -2.88% | $183.32B | +8.02% | 6.21% |
AWK | -2.36% | $27.37B | +4.54% | 2.22% |
AEP | -2.30% | $54.28B | +9.80% | 3.61% |
UUU | -1.60% | $4.93M | +40.20% | 0.00% |
PM | -1.56% | $263.27B | +68.03% | 3.17% |
PPC | -1.31% | $11.21B | +41.54% | 0.00% |
PULM | -1.11% | $23.82M | +239.64% | 0.00% |
VSTA | -0.63% | $326.82M | +11.64% | 0.00% |
MSIF | -0.52% | $715.25M | +28.42% | 7.05% |
BTCT | -0.49% | $25.35M | +93.08% | 0.00% |
AQB | -0.21% | $2.96M | -61.58% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -38.38% | $140.49M | 0.59% |
VIXY | -36.65% | $109.64M | 0.85% |
BTAL | -27.40% | $361.41M | 1.43% |
FXY | -17.89% | $838.61M | 0.4% |
IVOL | -16.78% | $353.94M | 1.02% |
FTSD | -16.25% | $212.46M | 0.25% |
SHYM | -15.91% | $322.93M | 0.35% |
XONE | -15.03% | $603.24M | 0.03% |
BSMW | -13.22% | $102.62M | 0.18% |
JMST | -13.17% | $3.65B | 0.18% |
ULST | -13.05% | $637.77M | 0.2% |
BILS | -12.96% | $3.96B | 0.1356% |
SPTS | -11.98% | $5.76B | 0.03% |
SCHO | -11.48% | $10.87B | 0.03% |
IBD | -10.51% | $380.12M | 0.43% |
VGSH | -10.01% | $22.38B | 0.03% |
STPZ | -9.60% | $446.46M | 0.2% |
LDUR | -9.25% | $849.09M | 0.5% |
UTWO | -9.19% | $387.71M | 0.15% |
IBTK | -9.13% | $431.59M | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | -0.06% | $23.29B | -11.36% | 1.23% |
VSA | 0.06% | $7.04M | -49.24% | 0.00% |
CL | -0.14% | $72.64B | -5.18% | 2.25% |
AQB | -0.21% | $2.96M | -61.58% | 0.00% |
OCFT | 0.22% | $265.28M | +232.26% | 0.00% |
HSY | 0.23% | $33.16B | -21.37% | 3.44% |
COR | 0.25% | $55.43B | +28.90% | 0.56% |
MKTX | 0.29% | $8.01B | -1.42% | 1.39% |
MSEX | 0.44% | $1.02B | -1.01% | 2.34% |
STG | 0.48% | $27.05M | -37.35% | 0.00% |
LRN | 0.48% | $6.69B | +118.03% | 0.00% |
BTCT | -0.49% | $25.35M | +93.08% | 0.00% |
MSIF | -0.52% | $715.25M | +28.42% | 7.05% |
TU | 0.57% | $23.77B | -4.62% | 7.19% |
VSTA | -0.63% | $326.82M | +11.64% | 0.00% |
SYPR | 0.74% | $37.69M | +21.48% | 0.00% |
AIFU | 0.77% | $9.85M | -95.03% | 0.00% |
DADA | 0.87% | $526.11M | +11.54% | 0.00% |
VHC | 0.93% | $34.69M | +74.89% | 0.00% |
PULM | -1.11% | $23.82M | +239.64% | 0.00% |
Yahoo
BEDFORD, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), a fully-integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor conferences in the second half of May 2025. 2025 RBC Capital Markets Global Healthcare Conference, May 20, 2025 Fireside Chat Date: Tuesday, May 20, 2025Fireside Chat Time: 2:35PM ETPresenter: Pravin U. Dugel, MD, Executive Chairman, President and C
Yahoo
One thing we could say about the analysts on Ocular Therapeutix, Inc. ( NASDAQ:OCUL ) - they aren't optimistic, having...
Yahoo
Ocular Therapeutix ( NASDAQ:OCUL ) First Quarter 2025 Results Key Financial Results Revenue: US$10.7m (down 28% from 1Q...
Yahoo
Ocular Therapeutix (OCUL) delivered earnings and revenue surprises of -27.59% and 37.36%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
BEDFORD, Mass. AP) — Ocular Therapeutix Inc. OCUL) on Monday reported a loss of $64.1 million in its first quarter.
Yahoo
AXPAXLI™ SOL trials for wet AMD progressing rapidly following recent updates to accelerate and enhance the registrational program Following positive FDA feedback for potential AXPAXLI NPDR registrational trial, Ocular is actively planning next steps in NPDR and DME SOL-1 retention remains exceptional as trial is on track for 1Q 2026 topline data readout SOL-R continues to have strong enrollment through streamlined, accelerated execution Cash balance of $349.7M as of March 31, 2025, with expected
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IAGG | -0.05% | $7.30B | 0.07% |
CORN | -0.10% | $49.57M | 0.2% |
PULS | -0.14% | $11.17B | 0.15% |
UUP | 0.16% | $292.27M | 0.77% |
SPAB | 0.16% | $8.75B | 0.03% |
GTIP | -0.17% | $145.27M | 0.12% |
MMIN | -0.18% | $469.53M | 0.3% |
BND | 0.19% | $125.46B | 0.03% |
MTBA | -0.20% | $1.56B | 0.17% |
AGG | 0.27% | $122.45B | 0.03% |
SGOV | 0.31% | $45.91B | 0.09% |
SCHZ | -0.33% | $8.47B | 0.03% |
UDN | -0.39% | $137.74M | 0.78% |
EDV | -0.43% | $3.32B | 0.05% |
BKAG | 0.48% | $1.86B | 0% |
MBB | 0.51% | $37.74B | 0.04% |
SCHP | -0.53% | $12.81B | 0.03% |
SUSB | -0.54% | $967.17M | 0.12% |
USDU | -0.55% | $173.44M | 0.5% |
USTB | 0.60% | $1.19B | 0.35% |